Waltz DA - Search Results

1

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Waltz DA, Natkin LR, Fujita RM, Wei Y, Chapman HA. Waltz DA, et al. J Clin Invest. 1997 Jul 1;100(1):58-67. doi: 10.1172/JCI119521. J Clin Invest. 1997. PMID: 9202057 Free PMC article.

2

Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy.

Waltz DA, Chapman HA. Waltz DA, et al. J Biol Chem. 1994 May 20;269(20):14746-50. J Biol Chem. 1994. PMID: 7514182 Free article.

3

Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Wei Y, et al. Among authors: waltz da. J Biol Chem. 1994 Dec 23;269(51):32380-8. J Biol Chem. 1994. PMID: 7528215 Free article.

4

Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.

Waltz DA, Sailor LZ, Chapman HA. Waltz DA, et al. J Clin Invest. 1993 Apr;91(4):1541-52. doi: 10.1172/JCI116360. J Clin Invest. 1993. PMID: 8386190 Free PMC article.

5

Role of urokinase receptor and caveolin in regulation of integrin signaling.

Chapman HA, Wei Y, Simon DI, Waltz DA. Chapman HA, et al. Among authors: waltz da. Thromb Haemost. 1999 Aug;82(2):291-7. Thromb Haemost. 1999. PMID: 10605716 Review.

6

Nonproteolytic role for the urokinase receptor in cellular migration in vivo.

Waltz DA, Fujita RM, Yang X, Natkin L, Zhuo S, Gerard CJ, Rosenberg S, Chapman HA. Waltz DA, et al. Am J Respir Cell Mol Biol. 2000 Mar;22(3):316-22. doi: 10.1165/ajrcmb.22.3.3713. Am J Respir Cell Mol Biol. 2000. PMID: 10696068

7

Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.

Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, Lipuma JJ, Gerard C, Goldmann D. Kalish LA, et al. Among authors: waltz da. Am J Respir Crit Care Med. 2006 Feb 15;173(4):421-5. doi: 10.1164/rccm.200503-344OC. Epub 2005 Nov 4. Am J Respir Crit Care Med. 2006. PMID: 16272450

8

Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis.

Uluer AZ, Waltz DA, Kalish LA, Adams S, Gerard C, Ericson DA. Uluer AZ, et al. Among authors: waltz da. J Cyst Fibros. 2013 Jan;12(1):54-9. doi: 10.1016/j.jcf.2012.06.006. Epub 2012 Oct 7. J Cyst Fibros. 2013. PMID: 23046902 Free article. Clinical Trial.

9

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators. Mayer-Hamblett N, et al. Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2. Pediatr Pulmonol. 2013. PMID: 23818295 Free PMC article. Clinical Trial.

10

FEV(1) as a guide to lung transplant referral in young patients with cystic fibrosis.

Robinson W, Waltz DA. Robinson W, et al. Among authors: waltz da. Pediatr Pulmonol. 2000 Sep;30(3):198-202. doi: 10.1002/1099-0496(200009)30:3<198::aid-ppul3>3.0.co;2-e. Pediatr Pulmonol. 2000. PMID: 10973037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters